NVO
Novo-Nordisk A/S
stockNYSEADR
At CloseOct 30, 2026 2:27:14 PM EDT
39.93USD+2.018%(+0.79)15,277,511
Pre-marketOct 30, 2026 9:29:30 AM EDT
39.62USD+1.226%(+0.48)
After-hoursOct 30, 2026 4:58:30 PM EDT
39.97USD+0.100%(+0.04)
Loading…
Loading…
176.12B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$39.14
Beta
0.95
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$41.23
SMA 200
$44.19
Avg. Vol 10D
9.33M
Avg. Vol 30D
13.38M
Avg. Vol 90D
11.98M
Relative Vol
1.14
4.41B
3.17B
71.94%
37,436,108
1.18%
3.11
54%/46%
46.25%
28.21%
0.2800%
10,000,000
1,902
13,684
121,034
Nov 4, 2026 (4d)
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Oct 31, 2026
Oct 30, 2026
This week’s top stock pitches from investment newsletters. · 
Stock Analysis Compilation
Oct 29, 2026
Novo Has Big Plans for 2030. Should You Buy the Stock Now? · 
The Motley Fool
Eli Lilly Shares Surge on Raised Sales Forecast · 
Bloomberg
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 39.05 | 2026-10-23 | +2.25% | -1.278 |
| 1M | 37.40 | 2026-10-01 | +6.76% | -0.329 |
| 3M | 47.08 | 2026-07-31 | -15.19% | -0.329 |
| 6M | 43.88 | 2026-05-01 | -9.00% | -0.133 |
| 1Y | 49.46 | 2025-10-31 | -19.27% | 0.954 |
| 2Y | 111.95 | 2024-10-31 | -64.33% | — |
| 5Y | 54.72 | 2021-11-01 | -27.03% | 0.664 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $39.93, and today's volume is 15,277,511. NVO is up 2.018% today. The 30 day average volume is 13.38M. NVO market cap is $176.12B with 4.41B shares outstanding.